Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q1 2024 ▲▼ | Q2 2024 ▲▼ | Change ▲▼ | Q1 2024 ▲▼ | Q2 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Ultragenyx Pharmaceutical Inc(RARE) | 110,000 | 1,800,000 | +1,690,000 | 5,136 | 73,980 | 5.52% | +68,844 |
| Exact Sciences Corp(EXK) | 100,000 | 925,000 | +825,000 | 6,906 | 39,081 | 2.91% | +32,175 |
| Janux Therapeutics Inc(JANX) | 0 | 725,000 | +725,000 | 0 | 30,370 | 2.26% | +30,370 |
| Arcellx Inc COMMON STOCK | 100,000 | 675,000 | +575,000 | 6,955 | 37,253 | 2.78% | +30,298 |
| Insmed Inc(INSM) | 750,000 | 750,000 | 0 | 20,348 | 50,250 | 3.75% | +29,903 |
| Jazz Pharmaceuticals PLC(JAZZ) | 1,100,000 | 1,500,000 | +400,000 | 132,462 | 160,095 | 11.94% | +27,633 |
| Savara Inc(SVRA) | 0 | 6,490,000 | +6,490,000 | 0 | 26,155 | 1.95% | +26,155 |
| iTeos Therapeutics Inc | 0 | 1,750,000 | +1,750,000 | 0 | 25,970 | 1.94% | +25,970 |
| Axsome Therapeutics Inc(AXSM) | 0 | 300,000 | +300,000 | 0 | 24,150 | 1.80% | +24,150 |
| Ascendis Pharma A/S(ASND) | 525,000 | 750,000 | +225,000 | 79,364 | 102,285 | 7.63% | +22,921 |
| Structure Therapeutics Inc | 0 | 560,000 | +560,000 | 0 | 21,991 | 1.64% | +21,991 |
| Bristol-Myers Squibb Co(BMY) | 0 | 500,000 | +500,000 | 0 | 20,765 | 1.55% | +20,765 |
| Immatics NV(IMTX) | 1,200,000 | 2,750,000 | +1,550,000 | 12,612 | 31,955 | 2.38% | +19,343 |
| KalVista Pharmaceuticals Inc | 655,000 | 2,300,000 | +1,645,000 | 7,768 | 27,094 | 2.02% | +19,326 |
| Day One Biopharmaceuticals Inc COM | 0 | 1,250,000 | +1,250,000 | 0 | 17,225 | 1.28% | +17,225 |
| Astria Therapeutics Inc | 1,100,000 | 3,250,000 | +2,150,000 | 15,483 | 29,575 | 2.21% | +14,093 |
| Immunome Inc(IMNM) | 0 | 1,000,000 | +1,000,000 | 0 | 12,100 | 0.90% | +12,100 |
| Denali Therapeutics Inc(DNLI) | 0 | 500,000 | +500,000 | 0 | 11,610 | 0.87% | +11,610 |
| Lexeo Therapeutics Inc | 175,000 | 840,000 | +665,000 | 2,744 | 13,474 | 1.00% | +10,730 |
| Nurix Therapeutics Inc(NRIX) | 0 | 500,000 | +500,000 | 0 | 10,435 | 0.78% | +10,435 |
| Black Diamond Therapeutics Inc | 0 | 2,100,000 | +2,100,000 | 0 | 9,786 | 0.73% | +9,786 |
| BioNTech SE(BNTX) | 0 | 100,000 | +100,000 | 0 | 8,036 | 0.60% | +8,036 |
| Inspire Medical Systems Inc(INSP) | 0 | 60,000 | +60,000 | 0 | 8,030 | 0.60% | +8,030 |
| Globus Medical Inc(GMED) | 1,000,000 | 900,000 | -100,000 | 53,640 | 61,641 | 4.60% | +8,001 |
| Dyne Therapeutics Inc(DYN) | 0 | 225,000 | +225,000 | 0 | 7,940 | 0.59% | +7,940 |
| Pacira BioSciences Inc(PCRX) | 80,000 | 280,000 | +200,000 | 2,338 | 8,011 | 0.60% | +5,673 |
| Praxis Precision Medicines Inc(PRAX) | 210,000 | 440,000 | +230,000 | 12,814 | 18,198 | 1.36% | +5,384 |
| Zymeworks Inc(ZYME) | 0 | 440,000 | +440,000 | 0 | 3,744 | 0.28% | +3,744 |
| Monte Rosa Therapeutics Inc(GLUE) | 0 | 890,000 | +890,000 | 0 | 3,329 | 0.25% | +3,329 |
| Xenon Pharmaceuticals Inc(XENE) | 400,000 | 525,000 | +125,000 | 17,220 | 20,470 | 1.53% | +3,250 |
| Ventyx Biosciences Inc | 0 | 1,315,000 | +1,315,000 | 0 | 3,038 | 0.23% | +3,038 |
| Alto Neuroscience Inc(ANRO) | 250,000 | 620,000 | +370,000 | 3,838 | 6,628 | 0.49% | +2,790 |
| PTC Therapeutics Inc(PTCT) | 0 | 90,000 | +90,000 | 0 | 2,752 | 0.21% | +2,752 |
| Verve Therapeutics Inc | 0 | 500,000 | +500,000 | 0 | 2,440 | 0.18% | +2,440 |
| Iovance Biotherapeutics Inc(IOVA) | 0 | 300,000 | +300,000 | 0 | 2,406 | 0.18% | +2,406 |
| Dianthus Therapeutics Inc(DNTH) | 455,000 | 600,000 | +145,000 | 13,650 | 15,528 | 1.16% | +1,878 |
| Solid Biosciences Inc | 1,035,000 | 2,665,000 | +1,630,000 | 13,786 | 15,111 | 1.13% | +1,324 |
| Atara Biotherapeutics Inc | 0 | 112,000 | +112,000 | 0 | 952 | 0.07% | +952 |
| Fate Therapeutics Inc | 800,000 | 2,000,000 | +1,200,000 | 5,872 | 6,560 | 0.49% | +688 |
| Fulcrum Therapeutics Inc | 695,000 | 1,160,000 | +465,000 | 6,561 | 7,192 | 0.54% | +631 |
| Newamsterdam Pharma Co NV ORDINARY SHARES | 0 | 25,000 | +25,000 | 0 | 480 | 0.04% | +480 |
| Reneo Pharmaceuticals Inc | 295,375 | 545,000 | +249,625 | 490 | 823 | 0.06% | +333 |
| Galapagos NV(LKFT) | 130,000 | 180,000 | +50,000 | 4,186 | 4,460 | 0.33% | +274 |
| Prime Medicine Inc | 360,000 | 450,000 | +90,000 | 2,520 | 2,313 | 0.17% | -207 |
| Chimerix Inc | 1,400,000 | 1,400,000 | 0 | 1,484 | 1,226 | 0.09% | -258 |
| Lyell Immunopharma Inc | 130,000 | 0 | -130,000 | 290 | 0 | — | -290 |
| Affimed NV | 55,000 | 0 | -55,000 | 292 | 0 | — | -291 |
| Apellis Pharmaceuticals Inc COM | 225,000 | 335,000 | +110,000 | 13,226 | 12,851 | 0.96% | -375 |
| Achilles Therapeutics PLC | 1,500,000 | 1,500,000 | 0 | 1,875 | 1,223 | 0.09% | -652 |
| Voyager Therapeutics Inc | 600,000 | 600,000 | 0 | 5,586 | 4,746 | 0.35% | -840 |
| BeiGene Ltd(ONC) | 325,000 | 350,000 | +25,000 | 50,827 | 49,935 | 3.72% | -892 |
| Allogene Therapeutics Inc | 1,350,000 | 2,200,000 | +850,000 | 6,035 | 5,126 | 0.38% | -908 |
| Passage Bio Inc | 4,500,000 | 6,052,000 | +1,552,000 | 6,075 | 4,806 | 0.36% | -1,269 |
| Atara Biotherapeutics Inc | 2,800,000 | 0 | -2,800,000 | 1,943 | 0 | — | -1,943 |
| Relmada Therapeutics Inc | 1,200,000 | 1,200,000 | 0 | 5,580 | 3,600 | 0.27% | -1,980 |
| Novavax Inc(NVAX) | 500,000 | 0 | -500,000 | 2,390 | 0 | — | -2,390 |
| uniQure NV(QURE) | 4,725,000 | 4,750,000 | +25,000 | 24,570 | 21,280 | 1.59% | -3,290 |
| Soleno Therapeutics Inc | 1,250,000 | 1,200,000 | -50,000 | 53,500 | 48,960 | 3.65% | -4,540 |
| Lyra Therapeutics Inc | 800,000 | 0 | -800,000 | 4,976 | 0 | — | -4,976 |
| Bio-Rad Laboratories Inc | 15,000 | 0 | -15,000 | 5,188 | 0 | — | -5,188 |
| Viking Therapeutics Inc(VKTX) | 75,000 | 0 | -75,000 | 6,150 | 0 | — | -6,150 |
| Geron Corp(GERN) | 2,200,000 | 0 | -2,200,000 | 7,260 | 0 | — | -7,260 |
| MacroGenics Inc | 725,000 | 800,000 | +75,000 | 10,672 | 3,400 | 0.25% | -7,272 |
| ALX Oncology Holdings Inc | 2,610,000 | 3,600,000 | +990,000 | 29,102 | 21,708 | 1.62% | -7,393 |
| Liquidia Corp(LQDA) | 2,000,000 | 1,830,000 | -170,000 | 29,500 | 21,960 | 1.64% | -7,540 |
| Krystal Biotech Inc(KRYS) | 45,000 | 0 | -45,000 | 8,007 | 0 | — | -8,007 |
| Shockwave Medical Inc | 25,000 | 0 | -25,000 | 8,141 | 0 | — | -8,141 |
| Applied Therapeutics Inc | 5,110,000 | 5,430,000 | +320,000 | 34,748 | 25,358 | 1.89% | -9,390 |
| Agios Pharmaceuticals Inc(AGIO) | 325,000 | 0 | -325,000 | 9,503 | 0 | — | -9,503 |
| Incyte Corp(INCY) | 200,000 | 0 | -200,000 | 11,394 | 0 | — | -11,394 |
| Sarepta Therapeutics Inc(SRPT) | 100,000 | 0 | -100,000 | 12,946 | 0 | — | -12,946 |
| Alpine Immune Sciences Inc | 350,000 | 0 | -350,000 | 13,874 | 0 | — | -13,874 |
| BioMarin Pharmaceutical Inc(BMRN) | 175,000 | 0 | -175,000 | 15,285 | 0 | — | -15,284 |
| TG Therapeutics Inc(TGTX) | 1,050,000 | 0 | -1,050,000 | 15,971 | 0 | — | -15,970 |
| Argenx SE(ARGX) | 50,000 | 0 | -50,000 | 19,686 | 0 | — | -19,686 |
| Inari Medical Inc | 800,000 | 350,000 | -450,000 | 38,384 | 16,853 | 1.26% | -21,531 |
| AstraZeneca PLC(AZN) | 400,000 | 0 | -400,000 | 27,100 | 0 | — | -27,100 |
| Cytokinetics Inc(CYTK) | 2,150,000 | 2,075,000 | -75,000 | 150,737 | 112,424 | 8.38% | -38,313 |
| Alnylam Pharmaceuticals Inc(ALNY) | 350,000 | 0 | -350,000 | 52,308 | 0 | — | -52,307 |
| Neurocrine Biosciences Inc(NBIX) | 710,000 | 0 | -710,000 | 97,923 | 0 | — | -97,923 |